Old Web
English
Sign In
Acemap
>
authorDetail
>
Marielle Pluyter
Marielle Pluyter
Genmab
CD20
Immunology
Monoclonal antibody
Antibody
Ofatumumab
4
Papers
763
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
cytolytic activity against non-Hodgkin lymphomas Characterization of new human CD20 monoclonal antibodies with potent
2013
Claude H. T. Chan
Paul Parren
C. Erik Hack
Michael Dechant
Thomas Valerius
L. Teeling
Ruth R. French
Mark S. Cragg
Jeroen van den Brakel
Marielle Pluyter
Show All
Source
Cite
Save
Citations (0)
Estimation of dose requirements for sustained in vivo activity of a therapeutic human anti‐CD20 antibody
2008
British Journal of Haematology
Wim K. Bleeker
Martin E. Munk
Wendy J.M. Mackus
Jeroen van den Brakel
Marielle Pluyter
Martin J. Glennie
Jan G. J. van de Winkel
Paul W. H. I. Parren
Show All
Source
Cite
Save
Citations (82)
Dual Mode of Action of a Human Anti-Epidermal Growth Factor Receptor Monoclonal Antibody for Cancer Therapy
2004
Journal of Immunology
Wim K. Bleeker
Jeroen J. Lammerts van Bueren
Heidi H. van Ojik
Arnout F. Gerritsen
Marielle Pluyter
Mischa Houtkamp
Ed Halk
Joel Goldstein
Janine Schuurman
Marc A. van Dijk
Jan G. J. van de Winkel
Paul W. H. I. Parren
Show All
Source
Cite
Save
Citations (137)
Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas.
2004
Blood
Jessica L. Teeling
Ruth R. French
Mark S. Cragg
Jeroen van den Brakel
Marielle Pluyter
Haichun Huang
Claude H. T. Chan
Paul W. H. I. Parren
C. Erik Hack
Michael Dechant
Thomas Valerius
Jan G. J. van de Winkel
Martin J. Glennie
Show All
Source
Cite
Save
Citations (544)
1